COVID-19

To boost infectious disease research post-pandemic, Europe should emulate the Crick’s dual approach of running basic research in parallel with translating discoveries to treatments, says Nobel prize winner Michael Houghton

Money will fund sequencing to pick up dangerous variants and trials network to test updated vaccines. Vaccines approvals will be eased and supply contracts modified. The initiatives are a dry run for the proposed Health Emergency Preparedness and Response Authority   

As the problem of COVID-19 vaccines supplies so potently illustrates, it is time to rethink the EU’s pandemic preparedness strategy. More support is needed for late stage clinical development and large scale manufacturing

Commission’s Sandra Gallina says spending more on advance purchase agreements would not have avoided the current supply problems, after days of criticism of the bloc's centralised procurement scheme

‘AstraZeneca has to deliver’, the EU’s health chief says, as row over supplies heats up and officials contradict claims made by pharma company’s CEO

Pharma company shoots down media report, as an extraordinary row over vaccines supply in Europe gets uglier

European Investment Bank warns innovation spending will be one of most affected areas of the economy as the COVID-19 crisis takes a toll

US biotech Moderna says its vaccine can be repurposed ‘in weeks’ to deal with coronavirus mutations

Open science has been at the heart of the fight-back against the virus. As other crises loom, this underlines the need for governments to avoid protectionist moves and foster collaborative international research